Skip to content

PHARMACIE BEGUIN

Active
Private limited company (pre-2019)founded 2007active for 19 yearsRue Louis Lahaye 220, 5300 Andenne, BelgiumKBO/BCE: BE 0889.508.014
Summary

PHARMACIE BEGUIN has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €451,282 and a net result of €86,982. Equity has been growing by about 7.3% per year since 2018. Its solvency ranks better than 76% of 12,777 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Official details

Source: KBO
Status
Active since 16-05-2007 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.162.779.504 5300 Andenne, since 10-05-2007
Financial year end
31 December
Peppol
Reachable since 08-12-2025

Board and ownership

Board

Financial position

88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Annual accounts 2025
Gross margin
€154,127
▼ 25.0%
Turnover
≈ €720,000
estimated
Profit
€86,982
▼ 32.0%
Equity
€451,282
▼ 2.8%
Total assets
€709,697
▼ 2.5%
Employees on 31-12-2025
2
=
  • 2025 accounts filed 31 days after the deadline
Score breakdownraises riskLast filed accounts filed 31 days late; 3 of the last 3 accounts latelowers riskFounded in 2007Equity €451,282 (63.6% of total assets)Liquidity: current ratio 3.24, cash €62,637Show the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 59% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 89=
equity 63.6% of total assets
Liquidity 49=
short-term debt 28.5% · cash 8.8%
Profitability 84-7
return on assets 12.3%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,281 companies, NACE 47, micro)
Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.3%▲ +0.1 percentage points vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025 08-2025: 0.5%▲ +0.1 percentage points vs 07-2025 09-2025: 0.6%▲ +0.1 percentage points vs 08-2025highest value 10-2025: 0.2%▼ -0.4 percentage points vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026lowest value 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.3%▲ +0.1 percentage points vs 06-2026 08-2026: 0.6%▲ +0.3 percentage points vs 07-2026 09-2026: 0.3%▼ -0.3 percentage points vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026 11-2026: 0.3%● unchanged vs 10-2026
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.24 (3.3 in 2024), above the usual 1.5. Short-term debt is 28.5% and cash 8.8% of total assets. 36.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 76% of them on solvency, 50% on liquidity, 78% on profitability and 34% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
raises risk · Last filed accounts filed 31 days late; 3 of the last 3 accounts late
NBB · filings
lowers risk · Founded in 2007
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €451,282 (63.6% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 3.24, cash €62,637
NBB · annual accounts
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
31 days late
2024
31 days late
2023
31 days late
2022
29 days late
2021
30 days late
2020
26 days early
2019
53 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 26 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €86,982 8 years View

Recent changes

  1. · Gazette deed Company renamed to Pharmacie BeguinResignation: LEJEUNE Bernadette Jeanne Marie Emma (gérante statutaire) · Appointment: BEGUIN Caroline Vanessa Virginie Stéphanie (statutory director)
  2. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as PHARMACIE BEGUIN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €598,000 and €814,000, founded between 2005 and 2010.

CompanyTotal assetsGross margin
PHARMACIE BEGUIN Andenne€709,697€154,127
LO-PHARMA Lubbeek€597,566€150,129
APOTHEEK op OVERSCHELDE Wetteren€745,559€138,865
APOTHEEK AERNOUT Tielt€688,443€185,506
PHARMACIE SANDRINE DERKENNE Verviers€814,390€180,198
UNIPHARM Veurne€716,027€128,221
MEPHARMA Merelbeke-Melle€701,341€185,943
Full comparison

Key facts about PHARMACIE BEGUIN

What is the company number of PHARMACIE BEGUIN?
The company number of PHARMACIE BEGUIN is 0889.508.014. The VAT number is the same number with BE in front: BE 0889.508.014.
Where is PHARMACIE BEGUIN based?
The registered office is at Rue Louis Lahaye 220, 5300 Andenne.Company details
What does PHARMACIE BEGUIN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE BEGUIN?
The legal form of PHARMACIE BEGUIN is Private limited company (pre-2019) (BVBA).
When was PHARMACIE BEGUIN founded?
PHARMACIE BEGUIN was founded on 16-05-2007.
Is PHARMACIE BEGUIN still active?
Yes, PHARMACIE BEGUIN is an active enterprise in the KBO register.
How many employees does PHARMACIE BEGUIN have?
PHARMACIE BEGUIN had an average of 1.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMACIE BEGUIN?
The turnover in financial year 2025 is ≈ €720,000. This figure is estimated from the gross margin of €154,127 and 51 comparable companies (NACE 477). It probably lies between €490,000 and €1.4m.
Is PHARMACIE BEGUIN profitable?
In financial year 2025, PHARMACIE BEGUIN made a profit of €86,982.
Where can I find the annual accounts of PHARMACIE BEGUIN?
PHARMACIE BEGUIN filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE BEGUIN due?
PHARMACIE BEGUIN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.